Voice of America’s Michelle Quinn reports that the “era of Silicon Valley’s operating largely free from government may be coming to an end.”
Read More
The New York Times' Steve Lohr, who has covered the tech industry for more than two decades, explains how we may be entering a progressive era of antitrust. He speaks with Open Markets Executive Director Barry Lynn on the changing political landscape. “The environment is radically different than it was even a year or two ago,” Lynn told him. “It’s a grass-roots rebellion against concentrated power.”
Read More
In response to a report by The New York Times that U.S. Department of Justice Assistant Attorney General for Antitrust Makan Delrahim substantively helped T-Mobile and Sprint merge, Open Markets Director of Enforcement Strategy Sally Hubbard makes the following statement.
Read More
The Open Markets Institute Team wishes you a happy holiday season! We know a lot of you will be taking advantage of these quiet cold days to catch up on your reading. Obviously, we hope this will include some time with Goliath: The 100-Year War Between Monopoly Power and Democracy. Our team is proud to have supported this important new history of how Americans debated economics in the 20th Century. But many other works also inspired us over the last year, and we hope you’ll have the time to read a few of them.
Read More
Open Markets Institute filed an amicus brief in support of theFederal Trade Commission in its case against Impax Laboratories. In our brief, we argue that pay-for-delay agreements are a form of per se illegal, horizontal market allocation agreements that seek to prohibit market entry and thus harm market competition.
Read More
Welcome to The Corner. In this issue, we discuss Impax Laboratories v. FTC and our latest amicus brief that we submitted in support of the FTC. We hope that all our readers have a happy and safe holiday. The Corner will return on January 9.
Read More
The Farm System Reform Act would halt construction of new concentrated animal feeding operations (CAFOs) and phase out all large CAFOs by 2040, while also holding corporate meatpackers more accountable for environmental degradation and farmer exploitation.
Read More
Today, the Open Markets Institute filed an amicus curiae brief in the Fifth Circuit Court of Appeals in support of the Federal Trade Commission (FTC) in its suit against generic drug maker Impax Laboratories.
Read More
“Open Markets has long called for reinvigorating the Packers & Stockyards Act," said Open Markets Institute's Food & Power Reporter Claire Kelloway. "This is a transformative step in challenging Big Ag’s monopoly power.”
Read More
On December 16, 2019, Open Markets Institute filed an amicus curiae brief in the Fifth Circuit Court of Appeals in support of the Federal Trade Commission (FTC) in its suit against generic drug maker Impax Laboratories.
Read More
The New York Times' Natasha Singer "reviews the week’s news, offering analysis about the most important developments in the tech industry." She cites Open Markets' Researcher and Reporter Matthew Buck's piece on the Washington Monthly, which argues that Amazon, Google and Facebook should stay out of health care, among "Stories You Shouldn't Miss."
Read More
The Washington Post's Tony Romm reports that regulators probing Facebook for violations of antitrust law have considered seeking a preliminary injunction against the company, aiming to halt the tech giant’s plans to integrate its social-networking app with the other services it owns. “At a time when Facebook is under scrutiny for its monopoly power and its abuses of its power, to say it’s going to integrate these three platforms is just another monopoly grab,” Open Markets Director of Enforcement Strategy Sally Hubbard told him.
Read More
White Paper: The Role of Monopoly in America’s Prescription Drug Crisis | White Paper: The Role of Hospitals in America’s Health Care Crisis
Read More
Tony Romm of The Washington Post reports on the federal investigation of Facebook’s antitrust violations and quotes Sally Hubbard, director of enforcement strategy at Open Markets Institute, opposing Facebook’s talk of integrating Facebook, Instagram, and WhatsApp.
Read More
Roger Parloff reports in Yahoo! Finance about the antitrust backlash against Big Tech and credits Open Markets Institute for elevating the issue and changing the debate.
Read More
On Yahoo Finance, Roger Parloff tells the story of how America has come to a turning point in its views of antitrust. He tracks the origins of the progressive neo-Brandesian movement and how key figures have played leading roles in igniting the Big Tech antitrust backlash in Washington including Tim Wu, Barry Lynn, Lina Khan, Matt Stoller, and Luther Lowe. Parloff quotes Former FTC chair William E. Kovacic who commented: "In five years, Barry and his group have changed the debate. They’ve gone from being a largely unnoticed fringe body of commentary to being at the very center of the debate.”
Read More
This report, “The Role of Monopoly in America’s Prescription Drug Crisis,” exposes how big pharma drives up drug costs through patent monopolies, abuses of regulations, and corporate consolidation.
Read More